4.1 Article

Comparative effectiveness of trauma-focused and non-trauma-focused psychotherapy for PTSD among veterans with comorbid substance use disorders: Protocol & rationale for a randomized clinical trial

期刊

CONTEMPORARY CLINICAL TRIALS
卷 120, 期 -, 页码 -

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cct.2022.106876

关键词

Posttraumatic stress disorder; Substance use disorders; Randomized clinical trial; Stakeholder engagement; Psychotherapy

资金

  1. Patient-Centered Outcomes Research Institute (PCORI) Award [PTSD-2019C1- 16009]

向作者/读者索取更多资源

This study aims to compare the effectiveness of trauma-focused therapy (TFT) and non-trauma-focused therapy (NTFT) for Veterans with PTSD and SUD. The study will examine the impact of varying SUD severity, type of substances used, and patient treatment preference.
Background: Co-occurrence of posttraumatic stress disorder (PTSD) and substance use disorders (SUDs) is com-mon and concurrent treatment is recommended. Relatively little is known about which evidence-based psy-chotherapies for PTSD are most effective for patients with varying substance use profiles. We aim to examine the comparative effectiveness of trauma-focused therapy (TFT) and non-trauma-focused therapy (NTFT) among Veterans with PTSD and SUD. TFT has been found to be effective among those with PTSD/SUD, though effects are smaller and rates of treatment non-completion are higher than in those without SUD. NTFTs suggested for the treatment of PTSD, such as Present Centered Therapy, (PCT) have not been examined among those with co-occurring SUD, despite lower rates of treatment dropout. We will also examine the comparative effectiveness of TFT and NTFT for patients with varying SUD severity, type of substances used, and patient treatment preference.Method: 420 Veterans with PTSD and SUD will be randomized in a prospective, pragmatic comparative effec-tiveness trial at 14 Veterans Health Administration facilities. Participants will receive either TFT (Prolonged Exposure or Cognitive Processing Therapy) or NTFT (PCT) after enrolling in concurrent SUD treatment-as-usual. Assessments will occur at baseline, posttreatment, 3-and 6-months posttreatment. Main outcomes are PTSD symptom severity and PTSD treatment dropout. Clinician, patient, and leadership stakeholder panels advise study activities, and a process evaluation will identify strategies to enhance the implementation of evidence -based PTSD treatments in SUD care settings.Conclusions: Results will provide critical information to guide clinicians when recommending PTSD treatments to patients with comorbid SUD.ClinicalTrials.gov Identifier: NCT04581434.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据